• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

打破循环:维生素D能否弥合多发性硬化症中肠道微生物群与免疫动力学之间的差距?

Breaking the Cycle: Can Vitamin D Bridge the Gap Between Gut Microbiota and Immune Dynamics in Multiple Sclerosis?

作者信息

Gençer Bingöl Feray, Kocyigit Emine, Çelik Elif, Ağagündüz Duygu, Budán Ferenc

机构信息

Department of Nutrition and Dietetics, Faculty of Health Sciences, Burdur Mehmet Akif Ersoy University, Burdur 15100, Türkiye.

Department of Nutrition and Dietetics, Faculty of Health Sciences, Ordu University, Ordu 52200, Türkiye.

出版信息

Int J Mol Sci. 2025 Jun 7;26(12):5464. doi: 10.3390/ijms26125464.

DOI:10.3390/ijms26125464
PMID:40564928
Abstract

Multiple Sclerosis (MS) is a chronic disease with autoimmune and neurodegenerative features that affect the nervous system. Genetic predisposition and environmental factors, such as vitamin D deficiency and dysbiosis activating a pro-inflammatory response, have a role in the etiology of the disease. In this context, the interactions of vitamin D with the gut microbiota and immune system have attracted attention in recent years. Vitamin D (1,25-dihydroxycholecalciferol) modulates the immune response by binding to the Vitamin D receptor (VDR). This pathway supports the functions of regulatory T cells by suppressing the activity of T helper cells 1 and 17 (Th1 and Th17). In MS patients, dysbiosis is characterized by a decrease in microbial diversity, and an increase in pro-inflammatory species is observed when compared to healthy individuals. Vitamin D has protective effects on eubiosis via VDR in intestinal epithelial cells, also reducing intestinal permeability by regulating tight junction proteins. In this way, vitamin D may contribute to the prevention of systemic inflammation. Although the relationship between vitamin D and the immune system is well documented, studies that address the triad of vitamin D level, gut microbiota, and immune response in MS are still limited.

摘要

多发性硬化症(MS)是一种具有自身免疫和神经退行性特征的慢性疾病,会影响神经系统。遗传易感性和环境因素,如维生素D缺乏和激活促炎反应的微生物群落失调,在该疾病的病因中起作用。在这种背景下,近年来维生素D与肠道微生物群和免疫系统的相互作用引起了关注。维生素D(1,25-二羟基胆钙化醇)通过与维生素D受体(VDR)结合来调节免疫反应。该途径通过抑制辅助性T细胞1和17(Th1和Th17)的活性来支持调节性T细胞的功能。在MS患者中,微生物群落失调的特征是微生物多样性降低,与健康个体相比,促炎物种增加。维生素D通过肠道上皮细胞中的VDR对正常微生物群落具有保护作用,还通过调节紧密连接蛋白来降低肠道通透性。通过这种方式,维生素D可能有助于预防全身炎症。尽管维生素D与免疫系统之间的关系已有充分记录,但针对MS中维生素D水平、肠道微生物群和免疫反应三者关系的研究仍然有限。

相似文献

1
Breaking the Cycle: Can Vitamin D Bridge the Gap Between Gut Microbiota and Immune Dynamics in Multiple Sclerosis?打破循环:维生素D能否弥合多发性硬化症中肠道微生物群与免疫动力学之间的差距?
Int J Mol Sci. 2025 Jun 7;26(12):5464. doi: 10.3390/ijms26125464.
2
Role of the intestinal flora-immunity axis in the pathogenesis of rheumatoid arthritis-mechanisms regulating short-chain fatty acids and Th17/Treg homeostasis.肠道菌群-免疫轴在类风湿关节炎发病机制中的作用——调节短链脂肪酸和Th17/Treg稳态的机制
Mol Biol Rep. 2025 Jun 21;52(1):617. doi: 10.1007/s11033-025-10714-w.
3
Microbial imbalance in the gut: a new frontier in Rheumatoid arthritis research.肠道微生物失衡:类风湿关节炎研究的新前沿。
Inflammopharmacology. 2025 Apr 12. doi: 10.1007/s10787-025-01737-7.
4
Changes in Gut Microbiota and Multiple Sclerosis: A Systematic Review.肠道微生物群与多发性硬化症的变化:系统评价。
Int J Environ Res Public Health. 2023 Mar 6;20(5):4624. doi: 10.3390/ijerph20054624.
5
Tailoring gut microbiota with a combination of Vitamin K and probiotics as a possible adjuvant in the treatment of rheumatic arthritis: a systematic review.用维生素 K 和益生菌联合定制肠道微生物群作为治疗风湿性关节炎的一种可能辅助手段:系统评价。
Clin Nutr ESPEN. 2022 Oct;51:37-49. doi: 10.1016/j.clnesp.2022.08.002. Epub 2022 Aug 7.
6
Synbiotics, prebiotics and probiotics for solid organ transplant recipients.固体器官移植受者的共生元、益生元和益生菌。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD014804. doi: 10.1002/14651858.CD014804.pub2.
7
Dysregulation and gene polymorphisms of Vitamin D receptor: its implications in lipid metabolic disorders.维生素D受体的失调与基因多态性:其在脂质代谢紊乱中的意义。
Mol Biol Rep. 2025 Jun 23;52(1):630. doi: 10.1007/s11033-025-10725-7.
8
Effectiveness and safety of vitamin D in relation to bone health.维生素D对骨骼健康的有效性与安全性。
Evid Rep Technol Assess (Full Rep). 2007 Aug(158):1-235.
9
Osteopontin protects from ovalbumin-induced asthma by preserving the microbiome and the intestinal barrier function.骨桥蛋白通过维持微生物群和肠道屏障功能来预防卵清蛋白诱导的哮喘。
mSystems. 2025 Jun 17;10(6):e0038925. doi: 10.1128/msystems.00389-25. Epub 2025 May 22.
10
Radiation-induced injury and the gut microbiota: insights from a microbial perspective.辐射诱导损伤与肠道微生物群:从微生物视角的见解
Therap Adv Gastroenterol. 2025 Jun 16;18:17562848251347347. doi: 10.1177/17562848251347347. eCollection 2025.

引用本文的文献

1
Research progress of SOCS in autoimmune diseases: mechanisms and therapeutic implications.细胞因子信号转导抑制因子在自身免疫性疾病中的研究进展:作用机制及治疗意义
Front Immunol. 2025 Jul 18;16:1604271. doi: 10.3389/fimmu.2025.1604271. eCollection 2025.

本文引用的文献

1
Gut microbiota and metabolites are linked to disease progression in multiple sclerosis.肠道微生物群和代谢产物与多发性硬化症的疾病进展有关。
Cell Rep Med. 2025 Apr 15;6(4):102055. doi: 10.1016/j.xcrm.2025.102055. Epub 2025 Apr 3.
2
Microbiota-produced immune regulatory bile acid metabolites control central nervous system autoimmunity.微生物群产生的免疫调节胆汁酸代谢产物控制中枢神经系统自身免疫。
Cell Rep Med. 2025 Apr 15;6(4):102028. doi: 10.1016/j.xcrm.2025.102028. Epub 2025 Mar 17.
3
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial.
大剂量维生素D治疗临床孤立综合征(典型多发性硬化症):D-Lay MS随机临床试验
JAMA. 2025 Apr 22;333(16):1413-1422. doi: 10.1001/jama.2025.1604.
4
The epidemiology, pathology and pathogenesis of MS: Therapeutic implications.多发性硬化症的流行病学、病理学及发病机制:治疗意义
Neurotherapeutics. 2025 Feb 27:e00539. doi: 10.1016/j.neurot.2025.e00539.
5
Vitamin D Supplementation Mediates a Shift toward Anti-Inflammatory Cytokine Response in Multiple Sclerosis.补充维生素D可介导多发性硬化症向抗炎细胞因子反应转变。
Med Princ Pract. 2025 Feb 12:1-9. doi: 10.1159/000544106.
6
Epidemiology of Multiple Sclerosis: Global, Regional, National and Sub-National-Level Estimates and Future Projections.多发性硬化症的流行病学:全球、区域、国家和次国家层面的估计及未来预测。
J Epidemiol Glob Health. 2025 Feb 10;15(1):21. doi: 10.1007/s44197-025-00353-6.
7
A Personalized Approach to Vitamin D Supplementation in Cardiovascular Health Beyond the Bone: An Expert Consensus by the Italian National Institute for Cardiovascular Research.意大利国家心血管病研究所关于骨骼之外心血管健康中维生素D补充的个性化方法:专家共识
Nutrients. 2024 Dec 30;17(1):115. doi: 10.3390/nu17010115.
8
The emerging role of microglia in the development and therapy of multiple sclerosis.小胶质细胞在多发性硬化症的发生发展及治疗中的新作用
Int Immunopharmacol. 2024 Dec 25;143(Pt 2):113476. doi: 10.1016/j.intimp.2024.113476. Epub 2024 Oct 30.
9
Blood-Brain Barrier Disruption in Neuroimmunological Disease.神经免疫性疾病中的血脑屏障破坏。
Int J Mol Sci. 2024 Oct 2;25(19):10625. doi: 10.3390/ijms251910625.
10
New therapeutic avenues in multiple sclerosis: Is there a place for gut microbiota-based treatments?多发性硬化症的新治疗途径:基于肠道微生物群的治疗方法是否有一席之地?
Pharmacol Res. 2024 Nov;209:107456. doi: 10.1016/j.phrs.2024.107456. Epub 2024 Oct 9.